$39.56
0.58% yesterday
Nasdaq, Nov 25, 10:02 pm CET
ISIN
US8688731004
Symbol
SRDX

Surmodics Inc Stock price

$39.56
+1.97 5.24% 1M
+5.18 15.07% 6M
+3.21 8.83% YTD
+5.83 17.28% 1Y
-8.29 17.33% 3Y
-2.44 5.81% 5Y
+18.13 84.60% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.23 0.58%
ISIN
US8688731004
Symbol
SRDX
Sector

Key metrics

Market capitalization $566.74m
Enterprise Value $559.87m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.44
P/S ratio (TTM) P/S ratio 4.50
P/B ratio (TTM) P/B ratio 4.77
Revenue growth (TTM) Revenue growth -4.91%
Revenue (TTM) Revenue $126.08m
EBIT (operating result TTM) EBIT $-1.89m
Free Cash Flow (TTM) Free Cash Flow $-3.24m
Cash position $40.11m
EPS (TTM) EPS $-0.81
P/E forward negative
P/S forward 4.03
EV/Sales forward 3.98
Short interest 3.13%
Show more

Is Surmodics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Surmodics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Surmodics Inc forecast:

3x Hold
100%

Analyst Opinions

3 Analysts have issued a Surmodics Inc forecast:

Hold
100%

Financial data from Surmodics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
126 126
5% 5%
100%
- Direct Costs 37 37
28% 28%
29%
90 90
14% 14%
71%
- Selling and Administrative Expenses 44 44
3% 3%
35%
- Research and Development Expense 38 38
18% 18%
30%
6.99 6.99
53% 53%
6%
- Depreciation and Amortization 8.88 8.88
3% 3%
7%
EBIT (Operating Income) EBIT -1.89 -1.89
134% 134%
-1%
Net Profit -12 -12
649% 649%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Surmodics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surmodics Inc Stock News

Neutral
Business Wire
20 days ago
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #SRDX--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2024. Fourth Quarter Fiscal 2024 Financial Summary Total Revenue of $33.2 million, an increase of 19% year-over-year Total Re...
Neutral
Business Wire
27 days ago
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that early results of a subset of 60 real-world acute, subacute, and chronic limb ischemia patients from its PROWL registry study were presented by Dr. Dean Ferrera at the 36th Annual TCT Symposium in Washing...
Neutral
Business Wire
about 2 months ago
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Pounce™ XL Thrombectomy System. The Pounce XL Thrombectomy System is indicated for the non-surgical removal of thrombi and emboli from the peripheral arter...
More Surmodics Inc News

Company Profile

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Head office United States
CEO Gary Maharaj
Employees 389
Founded 1979
Website www.surmodics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today